Evotec SE (EVO) Net Income (QoQ) (2009 - 2026)
Powered by 
Analysis
Evotec SE (EVO) Net Income (QoQ) (2009 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Iqvia Holdings | 42.77 Bn | 40.69 Bn | 1.44 Bn |
| 2 | Medpace Holdings | 16.50 Bn | 16.00 Bn | 201.64 Mn |
| 3 | Charles River Laboratories International | 13.37 Bn | 13.18 Bn | 452.07 Mn |
| 4 | Icon | 12.49 Bn | 11.56 Bn | 479.29 Mn |
| 5 | Fortrea Holdings | 1.58 Bn | 1.42 Bn | 139.20 Mn |
| 6 | Evotec SE | 642.83 Mn | 216.96 Mn | - |
| 7 | Ginkgo Bioworks Holdings | 422.55 Mn | 338.02 Mn | 18.44 Mn |
| 8 | Champions Oncology | 69.16 Mn | 69.16 Mn | 7.03 Mn |
| 9 | MindWalk Holdings | 59.83 Mn | 51.55 Mn | 1.82 Mn |
| 10 | VivoSim Labs | 1.45 Mn | 1.45 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -63.40% |
| Dec 31, 2025 | -73.45% |
| Sep 30, 2025 | -2.35% |
| Jun 30, 2025 | -48.17% |
| Mar 31, 2025 | -100.02% |
| Dec 31, 2024 | 481,857.87% |
| Sep 30, 2024 | 57.42% |
| Jun 30, 2024 | -355.20% |
| Mar 31, 2024 | -100.02% |
| Jun 30, 2023 | -411.89% |
| Mar 31, 2023 | -99.99% |
| Dec 31, 2022 | 71,040.69% |
| Sep 30, 2022 | 944.33% |
| Jun 30, 2022 | 63.74% |
| Mar 31, 2022 | -100.03% |
| Dec 31, 2021 | 155,418.68% |
| Sep 30, 2021 | 119.09% |
| Jun 30, 2021 | 13.69% |
| Mar 31, 2021 | -99.82% |
| Dec 31, 2020 | 1,813.49% |